Your browser doesn't support javascript.
loading
Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.
Alferink, Judith; Specht, Sabine; Arends, Hannah; Schumak, Beatrix; Schmidt, Kim; Ruland, Christina; Lundt, Ramona; Kemter, Andrea; Dlugos, Andrea; Kuepper, Janina M; Poppensieker, Karola; Findeiss, Matthias; Albayram, Önder; Otte, David-M; Marazzi, Janine; Gertsch, Jürg; Förster, Irmgard; Maier, Wolfgang; Scheu, Stefanie; Hoerauf, Achim; Zimmer, Andreas.
Affiliation
  • Alferink J; From the Institute of Molecular Psychiatry, Medical Faculty, and the Department of Psychiatry, University of Münster, 48149 Münster, Germany, the Cluster of Excellence EXC 1003, Cells in Motion, 48149 Münster, Germany, Judith.alferink@ukmuenster.de.
  • Specht S; the Institute of Medical Microbiology, Immunology, and Parasitology and.
  • Arends H; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Schumak B; the Institute of Medical Microbiology, Immunology, and Parasitology and.
  • Schmidt K; the Institute of Medical Microbiology, Immunology, and Parasitology and.
  • Ruland C; the Department of Psychiatry, University of Münster, 48149 Münster, Germany.
  • Lundt R; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Kemter A; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Dlugos A; the Department of Psychiatry, University of Münster, 48149 Münster, Germany.
  • Kuepper JM; the Institute of Medical Microbiology, Immunology, and Parasitology and.
  • Poppensieker K; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Findeiss M; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Albayram Ö; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Otte DM; From the Institute of Molecular Psychiatry, Medical Faculty, and.
  • Marazzi J; the Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland, and.
  • Gertsch J; the Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland, and.
  • Förster I; the Department of Immunology and Environment, Life and Medical Sciences Institute (LIMES), University of Bonn, 53127 Bonn, Germany.
  • Maier W; the Department of Psychiatry, University Hospital Bonn, 53105 Bonn, Germany.
  • Scheu S; the Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, 40225 Düsseldorf, Germany.
  • Hoerauf A; the Institute of Medical Microbiology, Immunology, and Parasitology and.
  • Zimmer A; From the Institute of Molecular Psychiatry, Medical Faculty, and neuro@uni-bonn.de.
J Biol Chem ; 291(37): 19517-31, 2016 09 09.
Article de En | MEDLINE | ID: mdl-27474745
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Plasmodium berghei / Barrière hémato-encéphalique / Paludisme cérébral / Récepteur cannabinoïde de type CB2 / Chimiokine CCL17 Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: J Biol Chem Année: 2016 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Plasmodium berghei / Barrière hémato-encéphalique / Paludisme cérébral / Récepteur cannabinoïde de type CB2 / Chimiokine CCL17 Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: J Biol Chem Année: 2016 Type de document: Article Pays de publication: États-Unis d'Amérique